CUped: An Approach to Motor Recovery Post-Stroke, not Compensation
CUped:中风后运动恢复的方法,而不是补偿
基本信息
- 批准号:10667869
- 负责人:
- 金额:$ 23.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-05 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptionAdverse eventBilateralClinicalCommunitiesCoupledDataDevelopmentDoseExerciseFunding OpportunitiesFutureGoalsHomeInterventionLaboratoriesLeftLimb structureLower ExtremityMeasuresMechanicsModelingMotorMovementMuscleNatureOutcomeOutputParesisParticipantPerformancePhasePhysiologicalProtocols documentationRandomized, Controlled TrialsRecoveryRehabilitation therapyResearchRewardsRiskRoboticsRunningSafetySpecific qualifier valueStrokeTarget PopulationsTechnologyTestingTherapeutic EffectTherapeutic exerciseTrainingUnited States National Institutes of HealthWalkingWorkdesigneffective interventioneffective therapyexercise interventiongait rehabilitationimprovedlimb movementmotor impairmentmotor recoverynovelnovel therapeuticspatient tolerabilitypost strokeresponserestorationstandard carestroke rehabilitationstroke survivortherapy designtreatment response
项目摘要
Project Summary
The goal of lower limb rehabilitation after stroke is recovery of independent walking at home and in the
community. Few stroke survivors achieve this goal. Suboptimal outcomes are due to the serious and
intransigent nature of movement impairments caused by stroke and the scarcity of feasible and effective
therapies that restore movement lost to stroke.
Our team has developed a novel exercise intervention called CUped (pronounced cupid, like the Roman god)
to address barriers to recovery and improve walking after stroke. CUped is so called because it compels use of
the paretic limb during a movement that resembles pedaling. This project will examine safety, acceptability,
and tolerance to CUped, characterize its therapeutic effects, and identify dose-response relationships. Results
will provide preliminary data for an R01 to support a randomized controlled trial (RCT).
CUped is designed to help stroke survivors recover lower limb movement lost to stroke, thereby improving
walking. It is intended to be used as an adjunct to gait training. CUped uses a robotic technology that
eliminates compensatory movements that interfere with recovery, compels use of the paretic lower limb, and
targets 3 key movement impairments caused by stroke: decreased muscle output from the paretic limb,
inappropriate paretic muscle timing, and abnormal interlimb coordination. Exercise is done in sitting which
enables high repetition practice. Like walking, CUped requires continuous, reciprocal use of both lower limbs;
effects are likely to transfer to walking.
The risk-reward profile of this proposal is ideal for an R21, which is an NIH funding opportunity intended to
encourage exploratory/developmental research by providing support for the early and conceptual stages of
project development. CUped is a novel therapy grounded in a physiologic premise and based on prior
observations from our laboratory. We have pilot data suggesting that CUped fulfills its design specifications,
and this study will be the first to test its therapeutic effects. In this Stage 1 rehabilitation trial, we will support or
quickly refute the hypothesis that CUped is safe, acceptable, and capable of eliciting a therapeutic response in
stroke survivors. We will also examine tolerance to CUped and dose-response effects. If our hypotheses are
supported, we will be poised to run an RCT to isolate the effects of CUped and compare them to standard
care. Future work will investigate physiologic mechanisms underlying the effects of CUped.
项目摘要
脑卒中后下肢康复的目标是恢复在家中和家中的独立行走。
社区很少有中风幸存者能达到这个目标。次优结局是由于严重和
中风引起的运动障碍的顽固性和缺乏可行有效的
恢复因中风而失去的运动的疗法。
我们的团队开发了一种新颖的运动干预,称为Cuped(发音为丘比特,像罗马神)
以解决中风后恢复障碍和改善行走。Cuped之所以被称为Cuped,是因为它强制使用
在类似于踩踏板的运动中麻痹的肢体。该项目将检查安全性,可接受性,
和耐受性,表征其治疗效果,并确定剂量-反应关系。结果
将为R 01提供初步数据,以支持随机对照试验(RCT)。
CUped旨在帮助中风幸存者恢复因中风而失去的下肢运动,从而改善
走路其预期用作步态训练的辅助工具。Cuped使用机器人技术,
消除干扰恢复的代偿性运动,强迫使用麻痹下肢,
针对中风引起的3种主要运动障碍:麻痹肢体的肌肉输出减少,
不适当的麻痹肌肉时机和异常的肢体间协调。运动是坐着进行的,
可以进行高重复练习。像走路一样,CUped需要两个下肢的持续、相互使用;
影响可能会转移到步行上。
该提案的风险回报概况非常适合R21,这是NIH的资助机会,旨在
通过为早期和概念阶段提供支持,鼓励探索性/发展性研究
项目开发。CUped是一种基于生理前提和基于先前的新疗法
我们实验室的观察。我们有试验数据表明CUped符合其设计规范,
这项研究将是第一个测试其治疗效果的研究。在第一阶段康复试验中,我们将支持或
迅速反驳了CUPed是安全的、可接受的、能够引起治疗反应的假设,
中风幸存者我们还将检查对CUped的耐受性和剂量反应效应。如果我们的假设
支持,我们将准备运行一个随机对照试验,以隔离CUped的影响,并将其与标准品进行比较。
在乎未来的工作将调查生理机制的影响,CUped。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHEILA M SCHINDLER-IVENS其他文献
SHEILA M SCHINDLER-IVENS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHEILA M SCHINDLER-IVENS', 18)}}的其他基金
Supraspinal Contributions to Locomotor Control and Recovery after Stroke
脊柱上对中风后运动控制和恢复的贡献
- 批准号:
8431356 - 财政年份:2010
- 资助金额:
$ 23.14万 - 项目类别:
Supraspinal Contributions to Locomotor Control and Recovery after Stroke
脊柱上对中风后运动控制和恢复的贡献
- 批准号:
8211033 - 财政年份:2010
- 资助金额:
$ 23.14万 - 项目类别:
Supraspinal Contributions to Locomotor Control and Recovery after Stroke
脊柱上对中风后运动控制和恢复的贡献
- 批准号:
8018971 - 财政年份:2010
- 资助金额:
$ 23.14万 - 项目类别:
Supraspinal Contributions to Locomotor Control and Recovery after Stroke
脊柱上对中风后运动控制和恢复的贡献
- 批准号:
7788641 - 财政年份:2010
- 资助金额:
$ 23.14万 - 项目类别:
Supraspinal Contributions to Locomotor Control and Recovery after Stroke
脊柱上对中风后运动控制和恢复的贡献
- 批准号:
8626178 - 财政年份:2010
- 资助金额:
$ 23.14万 - 项目类别:
ALTERED MUSCLE ACTIVITY DURING LOCOMOTION POST-STROKE
中风后运动过程中肌肉活动的改变
- 批准号:
6646243 - 财政年份:2003
- 资助金额:
$ 23.14万 - 项目类别:
ALTERED MUSCLE ACTIVITY DURING LOCOMOTION POST-STROKE
中风后运动过程中肌肉活动的改变
- 批准号:
6747622 - 财政年份:2003
- 资助金额:
$ 23.14万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 23.14万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 23.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 23.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 23.14万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 23.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 23.14万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 23.14万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 23.14万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 23.14万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 23.14万 - 项目类别:
Standard Grant